|
|
|
|
|
Use of Stability Studies in Drug, Combination Products & Medical Device Development are Reviewed in New Whitepaper
AGAWAM, MASS. — October 22, 2013 —The use
of stability testing in new product development — of drug substances, drug
products, combination products and some medical devices — is reviewed in a new
whitepaper from Microtest Laboratories, a leader in testing services and
contract manufacturing for the medical device, pharmaceutical, and
biotechnology industries.
Stability studies can help determine formulation and
manufacturing strategy, analytical assay development and validation — and help
explain unexpected and failing results. They can also provide input to
manufacturing controls, and help identify final packaging requirements. The
paper examines three specialized stability studies as examples:
- Forced degradation
studies,
which involve exposing the product to predetermined stress conditions in
order to intentionally form likely degradation products;
- Photostability
testing,
used to determine the product’s ability to withstand exposure to light
without any adverse effects;
- Temperature
cycling studies,
used to assess the impact of temperature changes on the product.
Two case studies, one involving
a drug product and one a combination product, are also presented.
The use of stability studies in the development of new drug or
combination products can ease both the planning and execution of a development
strategy. Moreover, the studies may also help prevent unnecessary costs and
time delays due to poor formulations, assay failures, and manufacturing
problems.
About
Microtest Laboratories
Microtest Laboratories is a leader in
testing services and contract manufacturing for the medical device,
pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts,
USA, the company provides expertise and flexible processes that enhance product
safety and security, accelerate time to market, and minimize supply chain
disruption. For more information, visit http://microtestlabs.com or call 1-413-786-1680
or toll-free 1-800-631-1680.
Labels: combination products, Medical Devices, pharmaceuticals, product development, stability studies, stability study, stability testing, white paper, whitepaper
“Combination Products: What You Need to Know” Seminar for Medical Device, Pharmaceutical Manufacturers is Scheduled for October 31st in Boston
A full-day technical seminar
designed to assist medical device and pharmaceuticals with what they need to
know about manufacturing combinations products, including best practices and applicable
FDA regulations, is scheduled for Thursday, October 31st, in
Waltham, Mass., just outside Boston.
Combination
products are a large and growing segment of the medical device market. Some
analysts estimate they represent more than 30% of all new FDA product
submissions. But for manufacturers, the convergence of drugs, biologics, and
devices presents a host of best practice and regulatory issues.
Titled “Combination Products: What You Need to Know,”
the seminar will outline a realistic approach for manufacturers
to navigate the testing, production, and regulatory standards related to the manufacture
of combination products. Topics will include:
- Combination Products —What You Need To
Know:
Overview of regulatory hurdles for combination products highlighting the
determination of PMOA.
- Applications of Lean to Combination
Product Manufacturing: Case studies specific to applying lean to
manufacturing of combo products for clinical use.
- In-Process and Release Testing PTC: Outline of
in-process and release testing points to consider during development and
specification determination.
- EM Monitoring of GMP Manufacturing
Space:
Current EM procedures for setting up GMP manufacturing.
- Choosing the Right CMO: Discussion of
best practices to determine a right fit CMO.
“Combination Products: What You Need to Know,”
will be presented by Microtest Laboratories, a leader in
testing services and contract manufacturing for the medical device,
pharmaceutical, and biotechnology industries. The seminar will be held at the Conference Center at Waltham Woods in Waltham, Mass., just
outside Boston, on Thursday, October 31, 2013, from 9:00 a.m. to 3:00 p.m. Registration
is at 9:00 a.m. Continental breakfast, break refreshments
and luncheon is included.
The seminar is one
in a continuing series of technical events presented by Microtest Laboratories for
medical device and pharmaceutical manufacturers. The seminars tend to fill up
quickly so please register early! Follow Microtest Laboratories on Facebook at http://goo.gl/pHNP63, on LinkedIn at http://goo.gl/H8ZLnM or on Twitter @MicrotestLabs.
Labels: best practices, Boston, combinations products, FDA regulations, manufacturing, Mass, medical device, pharmaceuticals, seminar, technical seminar, Waltham
|
|
|
|
|
|
|